related documents
- Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers. Conferences
- Arterial Stiffness in Older Adults With and Without Stroke Conferences
- Association Between Serum Leptin Levels and Stroke: Results from Framingham Heart Study Conferences
- Association between Paroxysmal Supraventricular Tachycardia and Ischemic Stroke in Patients Without Atrial Fibrillation. Conferences
- Cerebral Microbleeds and Cognition in Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes Trial Conferences
- Cerebral Microbleeds and Cognition: The Framingham Heart Study Conferences
- Cerebral Microbleeds and Physical performance: The Framingham Heart Study Conferences
- Cerebral Microbleeds and the Effect of Anticoagulation on Outcomes in 3699 Patients With Embolic Strokes of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. Conferences
- Cerebral Microbleeds are Associated With Incident Dementia: The Framingham Heart Study Conferences
- Cerebral Microbleeds in 1278 Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes (SPS3) Trial Conferences
- Cerebral Microbleeds in Transient Ischemic Attack and Minor Cerebrovascular Events Conferences
- Change in Antiplatelet Therapy in Prevention of Secondary Stroke (CAPS2) Study Conferences
- Characterization of Patients With Embolic Strokes of Uncertain Source in the Navigate-ESUS Trial Conferences
- Cognitive Profile of Non-demented Cerebral Amlyoid Angiopathy Patients Conferences
- Cortical Superficial Siderosis in Community-dwelling Subjects: The Framingham Heart and Rotterdam Studies Conferences
- Effect of Blood Pressure and Collateral Flow on Infarct Growth Rate Conferences
- Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From REVERSE AD. Conferences
- Effect of Oral Factor Xa Inhibitors on the Risk of Subdural Hematoma: COMPASS trial Results and Systematic Review Conferences
- First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study Conferences
- Frequency Aad Features of Patients With Embolic Strokes of Underdetermined Source (esus): Esus Global Registry Conferences
- Frequency of Intracranial Arterial Imaging and its Yield in Consecutive Patients with Non-lacunar Cryptogenic Ischemic Stroke: ESUS Global Registry Conferences
- High Serum Insulin-Like Growth Factor 1 is Associated with Lower Risk of Ischemic Stroke: The Framingham Heart Study Conferences
- Incidence and Etiology of Punctate Infarcts in Ischemic Stroke Patients Conferences
- Influence of Aversion to Uncertainty in STROKE Care. Conferences
- Mortality After Pediatric Arterial Ischemic Stroke: Results From the International Paediatric Stroke Study Conferences
- Patterns of Stroke Transfers and Predictors for Thrombectomy Post-MR CLEAN: a Single Center Experience Conferences
- Physicians' Preferences in the Management of Silent Stroke: Results From a Worldwide Survey. Conferences
- Prediction of Recurrent Stroke in Lacunar Stroke Patients: Performance of the Small Vessel Disease (SVD) Score in the SPS3 Trial Conferences
- Sensitivity and Reliability of MRI SWI Compared With GRE Sequences for Detecting Microbleeds in a Community Population Conferences